BloodJournal Article
27 Feb 2025
We have developed a cost-effective DNA methylation sequencing assay to improve monitoring of clonal hematopoiesis. By inferring cell-type proportions, this method enhances interpretation of clonal trajectories compared with interpretation based on variant allele fraction only.
Blood. 2025 Feb 27;145(9):907-908. doi: 10.1182/blood.2024027472.
More resources:
Share: